|
Market Closed -
Euronext Paris
02:55:00 13/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 36.65 EUR | +1.24% |
|
+6.23% | -14.87% |
| 21/09 | Neurones S.A.(ENXTPA:NRO) added to S&P Global BMI Index | CI |
| 10/09 | NEURONES Reaffirms Earnings Guidance for the Full Year of 2026 | CI |
Company Valuation: NEURONES
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 920.3 | 950.8 | 1,062 | 1,067 | 1,047 | 863.1 | - | - |
| Change | - | 3.32% | 11.69% | 0.47% | -1.89% | -17.54% | - | - |
| Enterprise Value (EV) 1 | 655.7 | 679 | 771.5 | 747.4 | 710.1 | 532 | 499.3 | 461.1 |
| Change | - | 3.56% | 13.62% | -3.13% | -4.99% | -25.08% | -6.14% | -7.65% |
| P/E | 24.5x | 21.6x | 21.6x | 20.3x | 20.1x | 15.5x | 13.9x | 12.6x |
| PBR | 2.95x | 2.87x | 3x | 2.82x | 2.62x | 2.09x | 1.96x | 1.84x |
| PEG | - | 1.2x | 1.9x | 3.17x | -21.71x | 1.76x | 1.2x | 1.2x |
| Capitalization / Revenue | 1.59x | 1.43x | 1.43x | 1.32x | 1.22x | 0.94x | 0.89x | 0.85x |
| EV / Revenue | 1.13x | 1.02x | 1.04x | 0.92x | 0.83x | 0.58x | 0.51x | 0.45x |
| EV / EBITDA | 8.6x | 7.59x | 8.33x | 7.82x | 7.46x | 5.17x | 4.4x | 3.72x |
| EV / EBIT | 10.6x | 9.31x | 10.2x | 9.59x | 9.39x | 6.44x | 5.41x | 4.52x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 1 | 1 | 1.2 | 1.3 | 1.4 | 1.5 | 1.6 | 1.7 |
| Rate of return | 2.63% | 2.55% | 2.74% | 2.96% | 3.25% | 4.14% | 4.42% | 4.7% |
| EPS 2 | 1.55 | 1.82 | 2.03 | 2.16 | 2.14 | 2.329 | 2.598 | 2.869 |
| Distribution rate | 64.5% | 54.9% | 59.1% | 60.2% | 65.4% | 64.4% | 61.6% | 59.2% |
| Net sales 1 | 579.9 | 665.4 | 741.2 | 810.4 | 857.2 | 917.2 | 972.2 | 1,021 |
| EBITDA 1 | 76.28 | 89.44 | 92.61 | 95.58 | 95.14 | 103 | 113.5 | 123.9 |
| EBIT 1 | 61.6 | 72.9 | 75.9 | 77.9 | 75.6 | 82.55 | 92.36 | 102.1 |
| Net income 1 | 37.7 | 44.3 | 49.4 | 52.5 | 52.1 | 56.77 | 63.33 | 69.95 |
| Net Debt 1 | -264.6 | -271.8 | -290.4 | -319.5 | -336.6 | -331.1 | -363.8 | -402 |
| Reference price 2 | 38.00 | 39.25 | 43.75 | 43.95 | 43.05 | 36.20 | 36.20 | 36.20 |
| Nbr of stocks (in thousands) | 24,218 | 24,224 | 24,272 | 24,274 | 24,313 | 23,842 | - | - |
| Announcement Date | 9/2/22 | 8/2/23 | 6/3/24 | 5/3/25 | 11/3/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 15.54x | 0.58x | 5.17x | 4.14% | 966M | ||
| 22.36x | 3.66x | 12.77x | 2.98% | 214B | ||
| 21.93x | 4.63x | 11.36x | 0.75% | 189B | ||
| -145.13x | 20.19x | 111.04x | -.--% | 130B | ||
| -622.65x | 44.3x | 182.01x | -.--% | 129B | ||
| 15.53x | 1.69x | 8.87x | 3.09% | 125B | ||
| 14.06x | 2.51x | 9.71x | 5.73% | 80.6B | ||
| 20.95x | 5.52x | 13.56x | 2.68% | 62.61B | ||
| 23.78x | 1.97x | 12.5x | 1.31% | 46.56B | ||
| -16.06x | 7.1x | 12.07x | -.--% | 45.27B | ||
| Average | -64.97x | 9.22x | 37.90x | 2.07% | 102.17B | |
| Weighted average by Cap. | -83.39x | 10.91x | 45.58x | 1.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- NRO Stock
- Valuation NEURONES
Select your edition
All financial news and data tailored to specific country editions
















